Search Results 631-640 of 18135 for corticosteroid

1. A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD) - Mayo Clinic

   - Initiation of treatment with systemic corticosteroids ... - Prior systemic treatment for aGVHD, except for the standard of care corticosteroid treatment ...

2. Childhood Asthma Clinical Trials - Mayo Clinic Research

   ... Corticosteroid Plus Long-acting β2 Agonist Rochester, MN. The purpose of this study is to continue to characterize the safety profile of benralizumab ...

3. A Study to Evaluate Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer - Mayo Clinic

   Not currently being treated with corticosteroids. No uncontrolled diabetes mellitus, defined by hemoglobin A1C greater than 8%; although A1C is not needed ...

4. Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma - Mayo Clinic

   ... corticosteroid (ICS). The low-dose ICS may be either as ICS monotherapy or as an ICS/long-acting beta agonist (LABA) combination. The ICS component of the ...

5. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

   Receiving chronic systemic corticosteroid therapy > 20 mg of prednisone daily. Being treated with other anti-cancer therapies (approved or investigational) ...

6. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid - Mayo Clinic

   The primary purpose of this study is to demonstrate that Dupilumab is superior to placebo in achieving sustained remission off oral corticosteroids (OCS) in ...

7. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

   ... corticosteroid therapy) and a dosage change is planned before Day 32. Note: topical agents and inhaled corticosteroid therapy use is permitted.

8. Emergency Care Clinical Trials - Mayo Clinic Research

   ... corticosteroids for community acquired pneumonia. Patients with severe community acquired pneumonia may benefit from adjunctive corticosteroid therapy. The ...

9. A Study to Evaluate M7824 with Concurrent Chemoradiation (cCRT) in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

   ... corticosteroids or systemic corticosteroids at physiological doses, which are not to exceed 10 mg/day of prednisone, or an equivalent corticosteroid.

10. A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency - Mayo Clinic

    Initiated low-dose corticosteroid ... Patients on a stable low-dose corticosteroid, bisphosphonate, or denosumab regimen are eligible and may continue treatment.